Učitavanje...
Apremilast ameliorates ox-LDL-induced endothelial dysfunction mediated by KLF6
Apremilast is a phosphodiesterase 4 (PDE4) inhibitor used in the treatment of psoriasis and several other inflammatory diseases. Interest has been expressed in seeking out therapies that address both psoriasis and atherosclerosis. In the present study, we explored the effects of apremilast in human...
Spremljeno u:
| Izdano u: | Aging (Albany NY) |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Impact Journals
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7732304/ https://ncbi.nlm.nih.gov/pubmed/33052879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.103665 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|